11/20
11:09 am
tars
Rating for TARS
Medium
Report
Rating for TARS
11/20
11:09 am
tars
Rating for TARS
Medium
Report
Rating for TARS
11/20
08:43 am
tars
Tarsus Pharmaceuticals (NASDAQ:TARS) is now covered by analysts at Mizuho. They set an "outperform" rating and a $100.00 price target on the stock.
Low
Report
Tarsus Pharmaceuticals (NASDAQ:TARS) is now covered by analysts at Mizuho. They set an "outperform" rating and a $100.00 price target on the stock.
11/20
08:43 am
tars
Tarsus Pharmaceuticals (NASDAQ:TARS) is now covered by analysts at Mizuho. They set an "outperform" rating and a $100.00 price target on the stock.
Low
Report
Tarsus Pharmaceuticals (NASDAQ:TARS) is now covered by analysts at Mizuho. They set an "outperform" rating and a $100.00 price target on the stock.
11/20
05:41 am
tars
Tarsus Pharmaceuticals initiated with an Outperform at Mizuho
Low
Report
Tarsus Pharmaceuticals initiated with an Outperform at Mizuho
11/20
05:41 am
tars
Tarsus Pharmaceuticals initiated with an Outperform at Mizuho
Low
Report
Tarsus Pharmaceuticals initiated with an Outperform at Mizuho
11/5
10:03 am
tars
Rating for TARS
Low
Report
Rating for TARS
11/5
10:03 am
tars
Rating for TARS
Low
Report
Rating for TARS
10/20
08:21 am
tars
Tarsus Pharmaceuticals (NASDAQ:TARS) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Tarsus Pharmaceuticals (NASDAQ:TARS) had its "buy" rating reaffirmed by analysts at HC Wainwright.